Steve O'Loughlin
Director of Finance/CFO presso ACTINIUM PHARMACEUTICALS, INC.
Patrimonio netto: 9 263 $ in data 31/03/2024
Profilo
Steve O'Loughlin is currently the Chief Financial & Accounting Officer at Actinium Pharmaceuticals, Inc. Prior to this, he was the Vice President-Corporate Finance & Development at Protea Biosciences Group, Inc. from 2012 to 2015.
He completed his undergraduate degree at Ramapo College of New Jersey.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 28/12/2023 | 1 183 ( 0.00% ) | 9 263 $ | 31/03/2024 |
Posizioni attive di Steve O'Loughlin
| Società | Posizione | Inizio |
|---|---|---|
| ACTINIUM PHARMACEUTICALS, INC. | Director of Finance/CFO | 15/05/2017 |
Precedenti posizioni note di Steve O'Loughlin
| Società | Posizione | Fine |
|---|---|---|
| PROTEA BIOSCIENCES GROUP, INC | Corporate Officer/Principal | 01/06/2015 |
Formazione di Steve O'Loughlin
| Ramapo College of New Jersey | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| ACTINIUM PHARMACEUTICALS, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Protea Biosciences Group, Inc.
 Protea Biosciences Group, Inc. Miscellaneous Commercial ServicesCommercial Services Protea Biosciences Group, Inc. engaged in the provision of molecular information services. It offers direct analysis, mapping, and display of biologically active molecules in living cells and tissue samples through its platform technology. The company was founded by Stephen C. Turner in July 2001 and was headquartered in Morgantown, WV. | Commercial Services |
- Borsa valori
- Insiders
- Steve O'Loughlin
